Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.94B | 1.75B | 1.87B | 1.83B | 1.83B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.94B | 1.75B | 1.87B | 1.83B | 1.83B |
| Cost of Revenue | 538.80M | 518.60M | 525.50M | 500.80M | 520.30M |
| Gross Profit | 1.40B | 1.24B | 1.34B | 1.33B | 1.30B |
| SG&A Expenses | 683.30M | 671.40M | 726.70M | 711.60M | 658.30M |
| Depreciation & Amortization | 144.90M | 145.00M | 138.20M | 133.40M | 131.50M |
| Other Operating Expenses | -- | -- | -- | -- | 11.40M |
| Total Operating Expenses | 1.48B | 1.45B | 1.51B | 1.46B | 1.43B |
| Operating Income | 459.80M | 301.70M | 361.10M | 374.80M | 395.60M |
| Income Before Tax | 284.50M | 219.30M | 276.70M | 286.80M | -74.80M |
| Income Tax Expenses | -135.20M | 56.40M | 66.90M | 54.10M | 55.40M |
| Earnings from Continuing Operations | 419.70M | 162.90M | 209.80M | 232.70M | -130.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -500.00K | -200.00K | -200.00K | -200.00K | -300.00K |
| Net Income | 419.20M | 162.70M | 209.60M | 232.50M | -130.50M |
| EBIT | 459.80M | 301.70M | 361.10M | 374.80M | 395.60M |
| EBITDA | 701.00M | 542.90M | 598.60M | 606.60M | 624.10M |
| EPS Basic | 2.02 | 0.78 | 1.00 | 1.11 | -0.62 |
| Normalized Basic EPS | 1.11 | 0.76 | 0.92 | 0.99 | 0.59 |
| EPS Diluted | 2.01 | 0.77 | 1.00 | 1.11 | -0.62 |
| Normalized Diluted EPS | 1.11 | 0.75 | 0.91 | 0.99 | 0.59 |
| Average Basic Shares Outstanding | 207.90M | 208.90M | 208.60M | 209.40M | 209.80M |
| Average Diluted Shares Outstanding | 208.60M | 210.00M | 209.90M | 210.40M | 209.80M |
| Dividend Per Share | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Payout Ratio | 11.98% | 30.79% | 24.00% | 21.63% | -38.62% |